Loading company…
Toxys B.V. is a Dutch biotech firm offering in vitro toxicity screening to identify hazardous and potentially carcinogenic compounds.
Its ToxTracker and ReproTracker assays assess genotoxic and teratogenic properties, serving pharmaceutical and chemical companies in North America, Europe, and Asia, and it also sells kits for in-house testing. Founded in 2014 and based in Leiden, Netherlands, the company raised EUR 2 million on March 10, 2020 from KIKK Capital and Rabobank Group, along with returning investors InnovationQuarter and Zeeland Investment Fund. Giel Hendriks is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in